Cardiovascular Outcomes in Patients With Primary Aldosteronism After Treatment

原发性醛固酮增多症 医学 心脏病学 螺内酯 内科学 血压 醛固酮 原发性高血压 心肌梗塞 优势比 肾上腺切除术 继发性高血压 临床终点 随机对照试验
作者
Cristiana Catena
出处
期刊:Archives of internal medicine [American Medical Association]
卷期号:168 (1): 80-80 被引量:512
标识
DOI:10.1001/archinternmed.2007.33
摘要

Background

Experimental and human studies demonstrate that long-term exposure to elevated aldosterone levels results in cardiac and vascular damage.

Methods

We investigated long-term cardiovascular outcomes in patients with primary aldosteronism after surgical or medical treatment. Fifty-four patients with or without evidence of adrenal adenomas were prospectively followed up for a mean of 7.4 years after treatment with adrenalectomy or spironolactone. Patients with primary aldosteronism were compared with patients with essential hypertension and were treated to reach a blood pressure of less than 140/90 mm Hg. The main outcome measure was a combined cardiovascular end point comprising myocardial infarction, stroke, any type of revascularization procedure, and sustained arrhythmias.

Results

At baseline, the prevalence of cardiovascular events was greater in primary aldosteronism (35%) than in essential hypertension (11%) (odds ratio, 4.61; 95% confidence interval, 2.38-8.95;P < .001), with odds ratios of 4.93, 4.36, and 2.80 for sustained arrhythmias, cerebrovascular events, and coronary heart disease, respectively. Blood pressure during follow-up was comparable in the primary aldosteronism and essential hypertension groups. Ten patients in the primary aldosteronism group and 19 in the essential hypertension group reached the primary end point (P = .85). Cox analysis indicated that older age and longer duration of hypertension were factors independently associated with the cardiovascular end point. Cardiovascular outcome was comparable in patients with aldosteronism treated with adrenalectomy vs aldosterone antagonists (P = .71).

Conclusion

Primary aldosteronism is associated with a cardiovascular complication rate out of proportion to blood pressure levels that benefits substantially from surgical and medical treatment in the long term.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
丘比特应助激昂的逊采纳,获得10
刚刚
小马甲应助秀丽誉采纳,获得10
刚刚
优雅的绿蓉完成签到 ,获得积分10
1秒前
SciGPT应助怕黑海冬采纳,获得10
1秒前
充电宝应助pgg采纳,获得10
1秒前
研友_nxer7Z发布了新的文献求助10
3秒前
冷艳惜梦关注了科研通微信公众号
4秒前
4秒前
zzz完成签到,获得积分10
4秒前
等于几都行完成签到 ,获得积分10
5秒前
6秒前
7秒前
maitiandehe发布了新的文献求助10
8秒前
鱼儿吐泡泡完成签到,获得积分10
10秒前
甲壳虫完成签到 ,获得积分10
10秒前
11秒前
科研通AI5应助科研通管家采纳,获得10
11秒前
科研通AI5应助科研通管家采纳,获得10
11秒前
NexusExplorer应助科研通管家采纳,获得10
11秒前
科研通AI5应助科研通管家采纳,获得10
11秒前
大个应助科研通管家采纳,获得10
12秒前
qikkk应助科研通管家采纳,获得10
12秒前
12秒前
Piper关注了科研通微信公众号
12秒前
12秒前
12秒前
脑洞疼应助科研通管家采纳,获得10
12秒前
13秒前
科研猫完成签到,获得积分10
14秒前
14秒前
今后应助遥远采纳,获得30
14秒前
激昂的逊发布了新的文献求助10
15秒前
李爱国应助ixueyi采纳,获得10
15秒前
秀丽誉完成签到,获得积分10
16秒前
16秒前
17秒前
18秒前
hanatae完成签到,获得积分10
18秒前
WDD完成签到,获得积分10
19秒前
张慧完成签到,获得积分10
20秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3976418
求助须知:如何正确求助?哪些是违规求助? 3520512
关于积分的说明 11203586
捐赠科研通 3257127
什么是DOI,文献DOI怎么找? 1798594
邀请新用户注册赠送积分活动 877804
科研通“疑难数据库(出版商)”最低求助积分说明 806523